Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Clinical trial NCT05380492 · UNKNOWN
Trial details
- NCT number
- NCT05380492
- Sponsor
- Perceive Biotherapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-17
- Primary completion
- 2025-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.